November 30 (SeeNews) - Bulgarian drug distributor Sopharma Trading [BUL:SO5] said on Thursday its sales revenue rose by an annual 9% to 545.1 million levs ($330.1 million/278.6 million euro) in the ten months through October.
The company’s pre-tax profit amounted to 12.7 million levs in the January-October period, Sopharma Trading said in a bourse filing.
In October alone, sales revenue increased by an annual 9% to 59.2 million levs.
The drug distributor’s pre-tax profit totalled 1.36 million levs in October.
Sopharma Trading closed 0.65% higher at 7.750 levs on the Sofia stock exchange on Wednesday. The company's shares had not traded by 1350 CET on Thursday.
(1 euro = 1.95583 levs)